“Drugmakers are now working on over 100 R&D projects designed to tackle diseases of the developing world and almost 80% of them are being carried out with non-industry partners,” according to a report (.pdf) released on Wednesday by the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA), Pharma Times reports.
Private Sector Involvement
Developing World Access To Medication: “Access to life-saving, essential medicines must be improved,” Josh Ruxin, founder and director of the Access Project and director of Rwanda Works,Â writes in a Forbes’ “Science Business” blog. After looking at the debate over whether the free market can help improve access and examining programs,…
“Just a small percentage of low- and middle-income countries’ healthcare budgets are allocated toward the treatment and prevention of chronic diseases even though such illnesses are expected to account for 69% of global deaths by 2030,” according to a paper published Wednesday in the Lancet, as part of a series on chronic disease and development, ModernHealthcare.com reports.
“The world’s biggest rich and emerging powers escalated a war of words over trade and currencies Thursday, as leaders opened a G20 summit [in Seoul, South Korea] struggling to iron out distortions that threaten global growth,” Agence France-Presse reports in an article examining some of the major disputes (Chan-Kyong, 11/11).
Nature News reports on an immunization campaign kicking off in Africa in December that will offer protection to some areas of Africa’s meningitis belt. “Millions will receive a new vaccine, MenAfriVac, that promises protection against the meningococcal bacterium Neisseria meningitides,” the news service writes, noting the effort “is the culmination of ten years’ work by an international consortium to develop a vaccine at a price low enough for massive use in Africa: just US$0.40 a dose.”
Al Jazeera Examines International Trade Agreement Negotiations, Access To Generic Medicines In Low-Income Countries
Al Jazeera examines what the outcomes of two international trade agreement negotiations â€“ one regarding free trade between the EU and India and the other over anti-counterfeiting measures â€“ could mean for patients living with HIV/AIDS in low-income countries.
In recent years, pharmaceutical companies in the Asia-Pacific region have ramped up their clinical trial activity, patent challenges of brand name drugs and their development of new products, according to report released Tuesday by CMR International, a Thomson Reuters business, Reuters reports.
African Private Sector Can Play Key Role In Improving Health Outcomes In Africa “The serious health problems afflicting our continent significantly affect our economies, reducing productivity, creating gaps in the workforce, causing innumerable sick days and restricting growth in African businesses,” First Lady of Rwanda Jeannette Kagame and CEO of…
Also In Global Health News: Canada’s Maternal Health Initiative; Mobile Giving; Interview With UNICEF Chief; Burning Biofuels And Anemia; ARVs In India
Sub-Saharan Africa To Receive Boost FromÂ Maternal, Child Health Initiative Canada will announce Monday “the 10 countries that will get help from the government’s $1.1-billion maternal and child health initiative,” 80 percentÂ of which is slated for sub-Saharan Africa, the Postmedia News/Vancouver Sun reports. The majority of the money will go to…
Global Agriculture Production Must Increase 70% By 2050 And Adapt To Climate Change, FAO Report Says
Agriculture production worlwide need to increase 70 percent by 2050 to meet global food demands, yet “billions of dollars in additional annual investment” are required to meet this goal and reduce the negative effects on the environment, the U.N. Food and Agriculture Organization (FAO) said in a report (.pdf) on Thursday, Reuters reports.